George, D. J., McDevitt, M. R., Barendswaard, E., Ma, D., Lai, L., Curcio, M. J., … Scheinberg, D. A. (2001). An α-particle emitting antibody ([²¹³Bi]J591) for radioimmmunotherapy of prostate cancer. Prostate Journal, 3(1), 1. https://doi.org/10.1046/j.1525-1411.2001.003001001.x

George, D. J., M. R. McDevitt, E. Barendswaard, D. Ma, L. Lai, M. J. Curcio, G. Sgouros, et al. “An α-particle emitting antibody ([²¹³Bi]J591) for radioimmmunotherapy of prostate cancer.” Prostate Journal 3, no. 1 (September 27, 2001): 1. https://doi.org/10.1046/j.1525-1411.2001.003001001.x.

George DJ, McDevitt MR, Barendswaard E, Ma D, Lai L, Curcio MJ, et al. An α-particle emitting antibody ([²¹³Bi]J591) for radioimmmunotherapy of prostate cancer. Prostate Journal. 2001 Sep 27;3(1):1.

George, D. J., et al. “An α-particle emitting antibody ([²¹³Bi]J591) for radioimmmunotherapy of prostate cancer.” Prostate Journal, vol. 3, no. 1, Sept. 2001, p. 1. Scopus, doi:10.1046/j.1525-1411.2001.003001001.x.

George DJ, McDevitt MR, Barendswaard E, Ma D, Lai L, Curcio MJ, Sgouros G, Ballangrud AM, Yang WH, Finn RD, Pellegrini V, Geerlings J, Lee M, Brechbiel MW, Bander NH, Cordon-Cardo C, Scheinberg DA. An α-particle emitting antibody ([²¹³Bi]J591) for radioimmmunotherapy of prostate cancer. Prostate Journal. 2001 Sep 27;3(1):1.